Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03586167 · ClinicalTrials.gov registry record · NA
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
A NA study of Refractive Errors, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 4
- Study locations
NCT03586167: Completed NA study of Refractive Errors, sponsored by Alcon Research.
NCT03586167 is a NA study of Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 88 participants, below the 101-participant average among 14 other Refractive Errors trials with a reported enrollment target (13% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03586167, a NA study of Refractive Errors, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess the clinical performance of an investigational, coated silicone hydrogel contact lens over approximately 30 days of daily wear.
Primary Outcome
VA was tested monocularly (each eye individually) without visual correction under photopic (well-lit) conditions. VA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.1 logMAR increment corresponding to 5 letters, or 1 line, on an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. A lower numeric value represents better visual acuity. Both eyes contributed to the analysis. No formal statistical hypothesis testing was planned.
Conditions Studied
Interventions
- DEVICE LID014341 contact lenses
- DEVICE Comfilcon A contact lenses
Study Locations (4)
Florida
- Alcon Investigative Site - Maitland
Georgia
- Alcon Investigative Site - Johns Creek
Illinois
- Alcon Investigative Site - Bloomington
Tennessee
- Alcon Investigative Site - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-09-27 |
| Phase | NA |
What the finished NCT03586167 record still lists
NCT03586167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 101-participant average among 14 other Refractive Errors trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 2 interventions - of which LID014341 contact lenses is the first listed.
NCT03586167 reports a single indexed study location in Florida, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT03586167 about?
NCT03586167 is a clinical study titled "Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens". The purpose of this study is to assess the clinical performance of an investigational, coated silicone hydrogel contact lens over approximately 30 days of daily wear.
What is the current status of trial NCT03586167?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-08-01. Estimated completion is 2018-09-27.
What conditions does trial NCT03586167 study?
This clinical trial studies the following conditions: Refractive Errors.
What interventions are being tested in trial NCT03586167?
The interventions under investigation include: LID014341 contact lenses (DEVICE), Comfilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03586167?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03586167 being conducted?
This trial has 4 study locations across Florida, Georgia, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03586167's enrollment target sits among peer trials
88 7th of 14 higher than 8 of 14 other Refractive Errors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Refractive Errors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
COMPLETED · NA
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
COMPLETED · NA
-
DD T2 Daily Disposable Registration Trial
COMPLETED · NA
-
Clinical Assessment of a HYDRAGLYDE® Regimen
COMPLETED · NA
-
Assessing Fitting Guides in Alcon Multifocal Contact Lenses
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI